Chemoinformaics analysis of 1-METHOXY-4-PROPAN-2-YLBENZENE
| Molecular Weight | 150.221 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 26 |
| Exact Molecular Weight | 150.104 | nRing | 1 |
| Solubility: LogS | -2.053 | nHRing | 0 |
| Solubility: LogP | -0.38 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 0 | BPOL | 15.7809 |
| QED | 0.087 |
| Synth | 4.74 |
| Natural Product Likeliness | 1.695 |
| NR-PPAR-gamma | 0.962 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.945 |
| HIA | 0.992 |
| CACO-2 | -6.435 |
| MDCK | 0.000041 |
| BBB | 0.285 |
| PPB | 0.948728 |
| VDSS | 0.317 |
| FU | 0.112276 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.023 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.506 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.188 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.018 |
| CL | 1.337 |
| T12 | 0.702 |
| hERG | 0.023 |
| Ames | 0.425 |
| ROA | 0.094 |
| SkinSen | 0.87 |
| Carcinogencity | 0.089 |
| EI | 0.007 |
| Respiratory | 0.016 |
| NR-Aromatase | 0.888 |
| Antiviral | No |
| Prediction | 0.90455 |